Article
Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
Annals of surgical oncology - 1 Sept 2020
Baumgartner Joel M, Riviere Paul, Lanman Richard B, Kelly Kaitlyn J, Veerapong Jula, Lowy Andrew M, Kurzrock Razelle
Abstract excerpt
BACKGROUND: Circulating tumor DNA (ctDNA) is a promising technology for treatment selection, prognostication, and surveillance after definitive therapy. Its use in the perioperative setting for patients with metastatic disease has not been well studied. We characterize perioperative plasma ctDNA and its association with progression-free survival (PFS) in patients undergoing surgery for peritoneal metastases....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.